Skip to main content
NCBI home page
Gut logoLink to Gut
. 1997 Feb;40(2):204–210. doi: 10.1136/gut.40.2.204

Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration.

M A Hull 1, A Knifton 1, B Filipowicz 1, J L Brough 1, G Vautier 1, C J Hawkey 1
PMCID: PMC1027049  PMID: 9071932

Abstract

BACKGROUND: Acid stable basic fibroblast growth factor (bFGF) promotes angiogenesis and healing of gastric ulcers in rats and reduces subsequent non-steroidal anti-inflammatory drug (NSAID) induced relapse. AIMS: To test in a double blind, placebo controlled, three way crossover study whether bFGF promotes healing and reduces subsequent relapse in a human model of gastric ulceration. SUBJECTS: Twelve healthy volunteers. METHODS: Subjects took aspirin 900 mg twice daily (days 1-3) with bFGF 0.1 mg twice daily or cimetidine 400 mg twice daily or placebo (days 1-14) and then indomethacin 50 mg thrice daily (days 15-21). Endoscopy was performed on days 1, 4, 8, 15, and 22 during each treatment period. Eight antral biopsy specimens were taken on day 1 and the number of unhealed biopsy induced mini-ulcers and NSAID induced erosions counted during subsequent endoscopies. RESULTS: Basic FGF and cimetidine were protective against aspirin and indomethacin induced duodenal (but not gastric) injury compared with placebo. There was significant relapse of biopsy induced mini-ulcers after indomethacin only in the placebo group (0 (0-0) before v 1 (0-4.5) after; p > 0.05). TGP-580 was detected in serum of one volunteer. CONCLUSIONS: Healing with bFGF (and cimetidine) was associated with reduced NSAID induced ulcer relapse in this model of gastric ulceration.

Full text

PDF
204

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baumgartner A., Koelz H. R., Halter F. Indomethacin and turnover of gastric mucosal cells in the rat. Am J Physiol. 1986 Jun;250(6 Pt 1):G830–G835. doi: 10.1152/ajpgi.1986.250.6.G830. [DOI] [PubMed] [Google Scholar]
  2. Boardman P. L., Hart F. D. Side-effects of indomethacin. Ann Rheum Dis. 1967 Mar;26(2):127–132. doi: 10.1136/ard.26.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bode G., Malfertheiner P., Mader U., Stanescu A., Ditschuneit H. Fine structure of active and healed duodenal ulcer. Am J Gastroenterol. 1991 Feb;86(2):179–186. [PubMed] [Google Scholar]
  4. Daneshmend T. K., Prichard P. J., Bhaskar N. K., Millns P. J., Hawkey C. J. Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine. Gastroenterology. 1989 Oct;97(4):944–949. doi: 10.1016/0016-5085(89)91502-3. [DOI] [PubMed] [Google Scholar]
  5. Dignass A. U., Tsunekawa S., Podolsky D. K. Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology. 1994 May;106(5):1254–1262. doi: 10.1016/0016-5085(94)90017-5. [DOI] [PubMed] [Google Scholar]
  6. Flott-Rahmel B., Gerdes W., Pechan P. A., Brysch W., Schlingensiepen K. H., Seifert W. bFGF induces its own gene expression in astrocytic and hippocampal cell cultures. Neuroreport. 1992 Dec;3(12):1077–1080. doi: 10.1097/00001756-199212000-00011. [DOI] [PubMed] [Google Scholar]
  7. Form D. M., Auerbach R. PGE2 and angiogenesis. Proc Soc Exp Biol Med. 1983 Feb;172(2):214–218. doi: 10.3181/00379727-172-41548. [DOI] [PubMed] [Google Scholar]
  8. Gospodarowicz D., Neufeld G., Schweigerer L. Fibroblast growth factor: structural and biological properties. J Cell Physiol Suppl. 1987;Suppl 5:15–26. doi: 10.1002/jcp.1041330405. [DOI] [PubMed] [Google Scholar]
  9. Graham D. Y., Agrawal N. M., Roth S. H. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet. 1988 Dec 3;2(8623):1277–1280. doi: 10.1016/s0140-6736(88)92892-9. [DOI] [PubMed] [Google Scholar]
  10. Guth P. H., Aures D., Paulsen G. Topical aspirin plus HCl gastric lesions in the rat. Cytoprotective effect of prostaglandin, cimetidine, and probanthine. Gastroenterology. 1979 Jan;76(1):88–93. [PubMed] [Google Scholar]
  11. Hanscom D. H., Buchman E. The Veterans Administration Cooperative Study on Gastric Ulcer. 4. The follow-up period. Gastroenterology. 1971 Oct;61(4 Suppl):585–591. [PubMed] [Google Scholar]
  12. Hawkey C. J. Non-steroidal anti-inflammatory drugs and peptic ulcers. BMJ. 1990 Feb 3;300(6720):278–284. doi: 10.1136/bmj.300.6720.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hawkey C. J. Synthesis of prostaglandin E2, thromboxane B2 and prostaglandin catabolism in gastritis and gastric ulcer. Gut. 1986 Dec;27(12):1484–1492. doi: 10.1136/gut.27.12.1484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hawkey C. J., Truelove S. C. Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay. Gut. 1981 Mar;22(3):190–193. doi: 10.1136/gut.22.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hudson N., Balsitis M., Everitt S., Hawkey C. J. Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs. Gut. 1995 Aug;37(2):191–194. doi: 10.1136/gut.37.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hudson N., Everitt S., Hawkey C. J. Interobserver variation in assessment of gastroduodenal lesions associated with non-steroidal anti-inflammatory drugs. Gut. 1994 Aug;35(8):1030–1032. doi: 10.1136/gut.35.8.1030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hull M. A., Cullen D. J., Hudson N., Hawkey C. J. Basic fibroblast growth factor treatment for non-steroidal anti-inflammatory drug associated gastric ulceration. Gut. 1995 Nov;37(5):610–612. doi: 10.1136/gut.37.5.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kawaguchi H., Pilbeam C. C., Gronowicz G., Abreu C., Fletcher B. S., Herschman H. R., Raisz L. G., Hurley M. M. Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J Clin Invest. 1995 Aug;96(2):923–930. doi: 10.1172/JCI118140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Konturek S. J., Brzozowski T., Majka J., Szlachcic A., Bielanski W., Stachura J., Otto W. Fibroblast growth factor in gastroprotection and ulcer healing: interaction with sucralfate. Gut. 1993 Jul;34(7):881–887. doi: 10.1136/gut.34.7.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Konturek S. J., Brzozowski T., Majka J., Szlachcic A., Bielanski W., Stachura J., Otto W. Fibroblast growth factor in gastroprotection and ulcer healing: interaction with sucralfate. Gut. 1993 Jul;34(7):881–887. doi: 10.1136/gut.34.7.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kumar A. Cimetidine: an immunomodulator. DICP. 1990 Mar;24(3):289–295. doi: 10.1177/106002809002400316. [DOI] [PubMed] [Google Scholar]
  22. Lancaster-Smith M. J., Jaderberg M. E., Jackson D. A. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Gut. 1991 Mar;32(3):252–255. doi: 10.1136/gut.32.3.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lanza F. L., Royer G. L., Jr, Nelson R. S., Chen T. T., Seckman C. E., Rack M. F. The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers: a gastroscopic and photographic study. Dig Dis Sci. 1979 Nov;24(11):823–828. doi: 10.1007/BF01324896. [DOI] [PubMed] [Google Scholar]
  24. Lanza F. L., Royer G. L., Jr, Nelson R. S., Chen T. T., Seckman C. E., Rack M. F. The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers: a gastroscopic and photographic study. Dig Dis Sci. 1979 Nov;24(11):823–828. doi: 10.1007/BF01324896. [DOI] [PubMed] [Google Scholar]
  25. Nicholson P. A. A review of the therapeutic efficacy of misoprostol, a prostaglandin E1 analogue. S Afr Med J. 1988 Jul 2;74 (Suppl):56–58. [PubMed] [Google Scholar]
  26. Paimela H., Goddard P. J., Carter K., Khakee R., McNeil P. L., Ito S., Silen W. Restitution of frog gastric mucosa in vitro: effect of basic fibroblast growth factor. Gastroenterology. 1993 May;104(5):1337–1345. doi: 10.1016/0016-5085(93)90342-a. [DOI] [PubMed] [Google Scholar]
  27. Peden N. R., Robertson A. J., Boyd E. J., Brown R. A., Gibbs J. H., Potts R. C., Wormsley K. G., Beck J. S. Mitogen stimulation of peripheral blood lymphocytes of duodenal ulcer patients during treatment with cimetidine or ranitidine. Gut. 1982 May;23(5):398–403. doi: 10.1136/gut.23.5.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Robinson M. G., Griffin J. W., Jr, Bowers J., Kogan F. J., Kogut D. G., Lanza F. L., Warner C. W. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci. 1989 Mar;34(3):424–428. doi: 10.1007/BF01536266. [DOI] [PubMed] [Google Scholar]
  29. Schmassmann A., Tarnawski A., Gerber H. A., Flogerzi B., Sanner M., Varga L., Halter F. Antacid provides better restoration of glandular structures within the gastric ulcer scar than omeprazole. Gut. 1994 Jul;35(7):896–904. doi: 10.1136/gut.35.7.896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Stadler P., Armstrong D., Margalith D., Saraga E., Stolte M., Lualdi P., Mautone G., Blum A. L. Diclofenac delays healing of gastroduodenal mucosal lesions. Double-blind, placebo-controlled endoscopic study in healthy volunteers. Dig Dis Sci. 1991 May;36(5):594–600. doi: 10.1007/BF01297025. [DOI] [PubMed] [Google Scholar]
  31. Szabo S., Folkman J., Vattay P., Morales R. E., Pinkus G. S., Kato K. Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats. Gastroenterology. 1994 Apr;106(4):1106–1111. doi: 10.1016/0016-5085(94)90773-0. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES